From The New Indian Express
Center Owned by Express Publications (Madurai) Ltd.Prices of 1,364 anti-cancer drug formulations revised, consumers set to save Rs 3,540 crore annually
What's behind this
Revised MRPs of 1,364 anti‑cancer formulations took effect on Monday, projected to save consumers about Rs 3,540.38 crore per year. The Department of Pharmaceuticals reported that 679 brands saw price cuts exceeding 50%, with the biggest reduction of 96.45%. The National Pharmaceutical Pricing Authority is the agency overseeing the pricing.
AI-generated overview from 3 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
left · 2 outlets
According to the Ministry, 85 pharmaceutical companies have reported revised MRPs for 1,364 anti-cancer formulations across 121 drugs as of November 8, 2026
-
center · 3 outlets
New Delhi: Revised Maximum Retail Prices (MRPs) of 1,364 anti-cancer formulations have come into effect from Monday, a move projected to save consumers an estimated Rs 3,540.38 crore annually, according to an official release. The National Pharmaceutical Pricing Authority (NPPA), functioning under…
RSS excerpt
NEW DELHI: Revised Maximum Retail Prices (MRPs) of 1,364 anti-cancer formulations have come into effect from Monday, a move projected to save consumers an estimated Rs 3,540.38 crore annually, according to an official release. The National Pharmaceutical Pricing Authority (NPPA), functioning under…
